Intismeran autogene with pembrolizumab shows a 49% reduction in recurrence or death risk in high-risk resected melanoma ...
Precigen, Inc. (Nasdaq: PGEN), a commercial-stage biopharmaceutical company specializing in the advancement of innovative ...
A new consensus document developed by The Blood Profiling Atlas in Cancer (BLOODPAC) Consortium was published in JCO ...
Underlying causes of recurrent pneumonia in children have changed in the last decade, indicating a need for individualized diagnostic approaches.
Researchers have developed a new computational approach that uncovers possible drugs for specific cellular targets for ...
Johns Hopkins biomedical engineers Ishan Vatsaraj, Stanley Chun Ming Wu, and Jaemyung Shin have been awarded highly ...
AI chip startup Etched.ai has reportedly raised $500 million in a funding round that was led by investment firm Stripes and ...
Published in JCO Precision Oncology, the new analytical validation standards offer an industry-wide protocol for test developersCHICAGO, Jan. 15, 2026 /PRNewswire/ -- A new consensus document ...
Discover how Markov chains predict real systems, from Ulam and von Neumann’s Monte Carlo to PageRank, so you can grasp ...
The EMA validation of T-DXd with pertuzumab could change the standard of care for HER2-positive metastatic breast cancer in ...
As new drugs and new regimens come to the fore, we have to remember that most patients receive care from the general oncology ...
Synergies: Leveraging DNA Methylation Data for AI-Driven Drug Discovery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback